InvestorsHub Logo
Followers 17
Posts 3780
Boards Moderated 0
Alias Born 02/21/2009

Re: I-Glow post# 51946

Wednesday, 03/31/2021 10:30:14 PM

Wednesday, March 31, 2021 10:30:14 PM

Post# of 64393
Here is what Deitsch has done for NPHC in 19 years:

Added Many patents and trademarks to Nutra's portfolio

Clinical Trials in Multiple Phases

1. Multiple Sclerosis Trials

2. Herpes Simplex Infections 1 & 2 Trials

3. Adrenomyeloneuropathy Trials

4. HIV Trials

5. Amyotrophic Lateral Sclerosis Trials

6. Rheumatoid Arthritis Trials

7. Pain Trials

Products launched and brought to Market

1. Cobroxin

2. Nyloxin

3. Pet Pain Away

4. Equine pain Away

Published Research

http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research

Increased Sales on Amazon and Walmart

RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis

Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC

Truth hurts...Being Short in NPHC hurts even more...

I guess some people have a different definition of accomplished anything!!

No one that is married to Nutra knows in 19 years he hasn't accomplished anything of value.


Nyloxin, I put that Sh*t on everything!!! $NPHC